PortfoliosLab logoPortfoliosLab logo
ISIN
US30205M1018
CUSIP
30205M101
IPO Date
May 22, 2018

Highlights

Market Cap
$20.14M
Enterprise Value
$17.54M
EPS (TTM)
-$1.55
Gross Profit (TTM)
-$157.00K
EBITDA (TTM)
-$8.38M
Year Range
$2.63 - $10.80
Target Price
$12.00
ROA (TTM)
-76.71%
ROE (TTM)
-466.35%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

XCUR Performance Chart

Exicure, Inc. (XCUR) is down 41.7% since the beginning of the year. At $3 per share, XCUR is trading 70.7% below its 52-week high of $11. Investors who bought $1,000 worth of XCUR shares 5 years ago would now be looking at an investment worth $13.


Loading charts...

S&P 500 Index

Returns By Period

Exicure, Inc. (XCUR) has returned -41.70% so far this year and -69.53% over the past 12 months.


Exicure, Inc.

1D
1.61%
1M
-2.77%
YTD
-41.70%
6M
-43.17%
1Y
-69.53%
3Y*
-11.11%
5Y*
-58.30%
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XCUR Monthly Returns History

Based on dividend-adjusted daily data since May 22, 2018, XCUR's average daily return is +0.06%, while the average monthly return is +4.43%. At this rate, an investment would double in approximately 1.3 years.

Historically, 34% of months were positive and 66% were negative. The best month was Nov 2024 with a return of +873.3%, while the worst month was Nov 2021 at -58.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, XCUR closed higher 41% of trading days. The best single day was Nov 20, 2024 with a return of +92.3%, while the worst single day was Dec 13, 2021 at -40.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-24.91%-8.11%13.76%-21.02%-5.06%-0.94%-41.70%
2025-17.85%-15.85%41.16%-21.66%-5.55%-28.67%1.28%-21.32%-27.09%7.58%-5.00%29.67%-60.35%
2024-6.87%31.39%-15.29%-14.21%-13.91%-27.96%36.91%-10.07%76.14%-12.68%873.27%-53.65%371.14%
202322.61%-17.73%-24.91%12.40%-10.01%48.69%-21.37%-11.65%-20.88%-12.50%-26.83%25.88%-49.54%
2022-1.63%0.75%-0.40%-29.82%-4.29%-46.27%-25.00%12.96%-14.21%-8.92%-30.07%15.00%-81.03%
202120.34%1.88%0.46%-9.63%-15.23%-10.18%-10.00%3.70%-14.29%-5.83%-58.50%-56.90%-88.58%

Benchmark Metrics

Exicure, Inc. has an annualized alpha of 4.05%, beta of 0.80, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since May 23, 2018.

  • This stock participated in 189.28% of S&P 500 Index downside but only -31.05% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4.05%
Beta
0.80
0.01
Upside Capture
-31.05%
Downside Capture
189.28%

Return for Risk

Risk / Return Rank

XCUR ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


XCUR Risk / Return Rank: 1313
Overall Rank
XCUR Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
XCUR Sortino Ratio Rank: 1515
Sortino Ratio Rank
XCUR Omega Ratio Rank: 1616
Omega Ratio Rank
XCUR Calmar Ratio Rank: 55
Calmar Ratio Rank
XCUR Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Exicure, Inc. (XCUR) and compare them to S&P 500 Index.


XCURBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.86

Sortino ratioReturn per unit of downside risk

-3.85

Omega ratioGain probability vs. loss probability

0.91

1.41

-0.50

Calmar ratioReturn relative to maximum drawdown

-0.93

2.93

-3.85

Martin ratioReturn relative to average drawdown

-1.27

13.52

-14.79

Dividends

Dividend History


Exicure, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Exicure, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Exicure, Inc. was 99.85%, occurring on Jul 9, 2024. The portfolio has not yet recovered.

The current Exicure, Inc. drawdown is 99.68%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-99.85%Jul 2024
5y 9mo
7y 8moSep 2018 - now
2018 bear market2018
-20.67%Aug 2018
1mo 5d1mo 18d
2mo 23dJun 2018 - Sep 2018
2018 pullback2018
-9.18%May 2018
1d12d
13dMay 2018 - Jun 2018
2018 pullback2018
-6.67%Jun 2018
0s3d
3dJun 2018 - Jun 2018
2018 pullback2018
-2.49%Jun 2018
1d4d
5dJun 2018 - Jun 2018

Drawdown Indicators


XCURBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.85%

-56.78%

-43.07%

Max Drawdown (1Y)

Largest decline over 1 year

-75.24%

-9.10%

-66.14%

Max Drawdown (3Y)

Largest decline over 3 years

-91.64%

-18.90%

-72.74%

Max Drawdown (5Y)

Largest decline over 5 years

-99.45%

-25.43%

-74.02%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-99.68%

-0.74%

-98.94%

Average Drawdown

Average peak-to-trough decline

-81.64%

-10.72%

-70.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.93%

1.97%

+52.96%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Exicure, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Exicure, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for XCUR in comparison with other companies in the Biotechnology industry. Currently, XCUR has a P/B value of 9.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with XCUR

Add Exicure, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with XCUR